Rennova Health Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, August 15, 2025.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 43.05B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -93.49% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.83 |
| Debt / FCF | 3.88 |
| Interest Coverage | 0.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 4.18% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -6.14% |
| Revenue Per Employee | 151,917 |
| Profits Per Employee | -62,839 |
| Employee Count | 149 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 34.37 |
Taxes
In the past 12 months, Rennova Health has paid 239,834 in taxes.
| Income Tax | 239,834 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 53.11 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.48 |
| Average Volume (20 Days) | 591,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rennova Health had revenue of 18.69 million and -7.73 million in losses. Loss per share was -0.00.
| Revenue | 18.69M |
| Gross Profit | 11.11M |
| Operating Income | 1.37M |
| Pretax Income | -314,044 |
| Net Income | -7.73M |
| EBITDA | 1.68M |
| EBIT | 1.37M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 49,015 in cash and 11.78 million in debt, giving a net cash position of -11.73 million.
| Cash & Cash Equivalents | 49,015 |
| Total Debt | 11.78M |
| Net Cash | -11.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -36.84M |
| Book Value Per Share | -0.00 |
| Working Capital | -35.56M |
Cash Flow
In the last 12 months, operating cash flow was 3.39 million and capital expenditures -350,934, giving a free cash flow of 3.04 million.
| Operating Cash Flow | 3.39M |
| Capital Expenditures | -350,934 |
| Free Cash Flow | 3.04M |
| FCF Per Share | n/a |
Margins
Gross margin is 59.46%, with operating and profit margins of 7.31% and -41.36%.
| Gross Margin | 59.46% |
| Operating Margin | 7.31% |
| Pretax Margin | -1.68% |
| Profit Margin | -41.36% |
| EBITDA Margin | 8.97% |
| EBIT Margin | 7.31% |
| FCF Margin | 16.25% |
Dividends & Yields
Rennova Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -228.51% |
| Shareholder Yield | -228.51% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 16, 2022. It was a reverse split with a ratio of 0.0001.
| Last Split Date | Mar 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |